Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-06
- Report ID: 1365
- Pages: 239
-
Format:
The global digital therapeutics market was valued at $2,238 million in 2018 and is expected to reach $9,640 million by 2026 with a CAGR of 19.9% during the forecast period.
Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.
Increase in adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 19.9% from 2019 to 2026. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.
The global digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employers, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2026, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Application
o Diabetes
o Obesity
o Cardiovascular Disease (CVD)
o Central Nervous System (CNS) Disease
o Respiratory Disease
o Smoking Cessation
o Gastrointestinal Disorder (GID)
o Others
By Product Type
o Software
o Device
By Product Type
o Business-to-Business (B2B)
Employer
Healthcare Provider
Others
o Business-to-Consumer (B2C)
Patient
Caregiver
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2018
3.3. PorterS Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase In Adoption of Smartphones And Tablets Coupled With Healthcare Apps
3.4.1.2. Growth In Need To Control Healthcare Costs
3.4.1.3. Rise In Incidence of Chronic Diseases
3.4.2. Restraints
3.4.2.1. Lack of Awareness Regarding Digital Therapeutics In Developing Countries
3.4.2.2. Patient Data Privacy Concerns
3.4.3. Opportunity
3.4.3.1. Emerging Markets offer Significant Growth Opportunities
Chapter 4: Digital Therapeutics Market, By Application
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Diabetes
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Analysis, By Country
4.3. Obesity
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country
4.4. Cardiovascular Diseases
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast
4.4.3. Market Analysis, By Country
4.5. Central Nervous System (Cns) Diseases
4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
4.6. Gastrointestinal Disorder
4.6.1. Key Market Trends And Growth Opportunities
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country
4.7. Respiratory Diseases
4.7.1. Key Market Trends And Growth Opportunities
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country
4.8. Smoking Cessation
4.8.1. Key Market Trends And Growth Opportunities
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country
4.9. Others
4.9.1. Key Market Trends And Growth Opportunities
4.9.2. Market Size And Forecast
4.9.3. Market Analysis, By Country
Chapter 5: Digital Therapeutics Market, By Product
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Software
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Devices
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country
Chapter 6: Digital Therapeutics Market, By Sales Channel
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Business-To-Business (B2B)
6.2.1. Market Size And Forecast, By Type
6.2.2. Employer
6.2.2.1. Market Size And Forecast
6.2.3. Healthcare Providers
6.2.3.1. Market Size And Forecast
6.2.4. Others
6.2.4.1. Market Size And Forecast
6.2.5. Market Size And Forecast, By Region
6.2.6. Market Analysis, By Country
6.3. Business-To-Consumers
6.3.1. Market Size And Forecast, By Type
6.3.2. Patients
6.3.2.1. Market Size And Forecast
6.3.3. Caregivers
6.3.3.1. Market Size And Forecast
6.3.4. Market Size And Forecast, By Region
6.3.5. Market Analysis, By Country
Chapter 7: Digital Therapeutics Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. North America Digital Therapeutics Market, By Country
7.2.2.1. U.S. Digital Therapeutics Market, By Application
7.2.2.2. U.S Digital Therapeutics Market, By Product Type
7.2.2.3. U.S. Digital Therapeutics Market, By Sales Channel
7.2.2.4. Canada Digital Therapeutics Market, By Application
7.2.2.5. Canada Digital Therapeutics Market, By Product Type
7.2.2.6. Canada Digital Therapeutics Market, By Sales Channel
7.2.2.7. Mexico Digital Therapeutics Market, By Application
7.2.2.8. Mexico Digital Therapeutics Market, By Product Type
7.2.2.9. Mexico Digital Therapeutics Market, By Sales Channel
7.2.3. North America Digital Therapeutics Market, By Application
7.2.4. North America Digital Therapeutics Market, By Product Type
7.2.5. North America Digital Therapeutics Market, By Sales Channel
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Europe Digital Therapeutics Market, By Country
7.3.2.1. Uk Digital Therapeutics Market, By Application
7.3.2.2. Uk Digital Therapeutics Market, By Product Type
7.3.2.3. Uk Digital Therapeutics Market, By Sales Channel
7.3.2.4. Germany Digital Therapeutics Market, By Application
7.3.2.5. Germany Digital Therapeutics Market, By Product Type
7.3.2.6. Germany Digital Therapeutics Market, By Sales Channel
7.3.2.7. France Digital Therapeutics Market, By Application
7.3.2.8. France Digital Therapeutics Market, By Product Type
7.3.2.9. France Digital Therapeutics Market, By Sales Channel
7.3.2.10. Italy Digital Therapeutics Market, By Application
7.3.2.11. Italy Digital Therapeutics Market, By Product Type
7.3.2.12. Italy Digital Therapeutics Market, By Sales Channel
7.3.2.13. Spain Digital Therapeutics Market, By Application
7.3.2.14. Spain Digital Therapeutics Market, By Product Type
7.3.2.15. Spain Digital Therapeutics Market, By Sales Channel
7.3.2.16. Rest of Europe Digital Therapeutics Market, By Application
7.3.2.17. Rest of Europe Digital Therapeutics Market, By Product Type
7.3.2.18. Rest of Europe Digital Therapeutics Market, By Sales Channel
7.3.3. Europe Digital Therapeutics Market, By Application
7.3.4. Europe Digital Therapeutics Market, By Product Type
7.3.5. Europe Digital Therapeutics Market, By Sales Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Asia-Pacific Digital Therapeutics Market, By Country
7.4.2.1. Japan Digital Therapeutics Market, By Application
7.4.2.2. Japan Digital Therapeutics Market, By Product Type
7.4.2.3. Japan Digital Therapeutics Market, By Sales Channel
7.4.2.4. China Digital Therapeutics Market, By Application
7.4.2.5. China Digital Therapeutics Market, By Product Type
7.4.2.6. China Digital Therapeutics Market, By Sales Channel
7.4.2.7. Australia Digital Therapeutics Market, By Application
7.4.2.8. Australia Digital Therapeutics Market, By Product Type
7.4.2.9. Australia Digital Therapeutics Market, By Sales Channel
7.4.2.10. India Digital Therapeutics Market, By Application
7.4.2.11. India Digital Therapeutics Market, By Product Type
7.4.2.12. India Digital Therapeutics Market, By Sales Channel
7.4.2.13. South Korea Digital Therapeutics Market, By Application
7.4.2.14. South Korea Digital Therapeutics Market, By Product Type
7.4.2.15. South Korea Digital Therapeutics Market, By Sales Channel
7.4.2.16. Rest of Asia-Pacific Digital Therapeutics Market, By Application
7.4.2.17. Rest of Asia-Pacific Digital Therapeutics Market, By Product Type
7.4.2.18. Rest of Asia-Pacific Digital Therapeutics Market, By Sales Channel
7.4.3. Asia-Pacific Digital Therapeutics Market, By Application
7.4.4. Asia-Pacific Digital Therapeutics Market, By Product Type
7.4.5. Asia-Pacific Digital Therapeutics Market, By Sales Channel
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Lamea Digital Therapeutics Market, By Country
7.5.2.1. Brazil Digital Therapeutics Market, By Application
7.5.2.2. Brazil Digital Therapeutics Market, By Product Type
7.5.2.3. Brazil Digital Therapeutics Market, By Sales Channel
7.5.2.4. Turkey Digital Therapeutics Market, By Application
7.5.2.5. Turkey Digital Therapeutics Market, By Product Type
7.5.2.6. Turkey Digital Therapeutics Market, By Sales Channel
7.5.2.7. Saudi Arabia Digital Therapeutics Market, By Application
7.5.2.8. Saudi Arabia Digital Therapeutics Market, By Product Type
7.5.2.9. Saudi Arabia Digital Therapeutics Market, By Sales Channel
7.5.2.10. South Africa Digital Therapeutics Market, By Application
7.5.2.11. South Africa Digital Therapeutics Market, By Product Type
7.5.2.12. South Africa Digital Therapeutics Market, By Sales Channel
7.5.2.13. Rest of Lamea Digital Therapeutics Market, By Application
7.5.2.14. Rest of Lamea Digital Therapeutics Market, By Product Type
7.5.2.15. Rest of Lamea Digital Therapeutics Market, By Sales Channel
7.5.3. Lamea Digital Therapeutics Market, By Application
7.5.4. Lamea Digital Therapeutics Market, By Product Type
7.5.5. Lamea Digital Therapeutics Market, By Sales Channel
Chapter 8: Company Profiles
8.1. 2Morrow, Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Key Strategic Moves And Developments
8.2. Fitbit, Inc. (Twine Health, Inc.)
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Product Portfolio
8.2.4. Business Performance
8.2.5. Key Strategic Moves And Developments
8.3. Livongo Health, Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Product Portfolio
8.3.4. Key Strategic Moves And Developments
8.4. Medtronic Plc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.4.6. Key Strategic Moves And Developments
8.5. Omada Health, Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Key Strategic Moves And Developments
8.6. Pear Therapeutics, Inc.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Product Portfolio
8.6.4. Key Strategic Moves And Developments
8.7. Proteus Digital Health, Inc.
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Key Strategic Moves And Developments
8.8. Resmed, Inc. (Propeller Health)
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves And Developments
8.9. Voluntis, Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.9.6. Key Strategic Moves And Developments
8.10. Welldoc, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Key Strategic Moves And Developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
